The Patent Finder

SJP Biotec GmbH

18 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 23, 2027
    The maintenance fee for Piperidine-Substituted MNK Inhibitors and Methods Related Thereto (US 11,878,015) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
  • 2 fees due Sep 3, 2027
  • 1 fee due Oct 9, 2027
    The maintenance fee for Crystalline Forms of MNK Inhibitors (US 11,952,375) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,993,494Compositions and Methods for Treating Fibrotic Disease
In force
 · High confidence
In forceHigh confidence
US 10,576,098Compositions and Methods for Treating Fibrotic Disease
In force
 · High confidence
In forceHigh confidence
US 9,382,248MNK Inhibitors and Methods Related Thereto
In force
 · High confidence
In forceHigh confidence
US 9,669,031MNK Inhibitors and Methods Related Thereto
In force
 · High confidence
In forceHigh confidence
US 9,814,718MNK Inhibitors and Methods Related Thereto
In force
 · High confidence
In forceHigh confidence
US 10,112,955Isoindoline, Azaisoindoline, Dihydroindenone and Dihydroazaindenone Inhibitors of MNK1 and MNK2
In force
 · High confidence
In forceHigh confidence
US 10,000,487Heterocyclic Compounds That Inhibit the Kinase Activity of MNK Useful for Treating Various Cancers
In force
 · High confidence
In forceHigh confidence
US 9,957,277EIF4A-INHIBITING Compounds and Methods Related Thereto
In force
 · High confidence
In forceHigh confidence
US 10,577,378EIF4A-INHIBITING Compounds and Methods Related Thereto
In force
 · High confidence
In forceHigh confidence
US 11,440,917EIF4A-INHIBITING Compounds and Methods Related Thereto
In force
 · Medium confidence
In forceMedium confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited